Oxidative stress including
iron excess has been associated with
carcinogenesis. The level of
8-oxoguanine, a major oxidatively modified base in
DNA, is maintained very low by three distinct
enzymes, encoded by OGG1, MUTYH and MTH1. Germline biallelic inactivation of MUTYH represents a familial
cancer syndrome called MUTYH-associated polyposis. Here, we used Mutyh-deficient mice to evaluate renal
carcinogenesis induced by
ferric nitrilotriacetate (
Fe-NTA). Although the C57BL/6 background is
cancer-resistant, a repeated intraperitoneal administration of
Fe-NTA induced a high incidence of
renal cell carcinoma (RCC; 26.7%) in Mutyh-deficient mice in comparison to wild-type mice (7.1%).
Fe-NTA treatment also induced renal
malignant lymphoma, which did not occur without the
Fe-NTA treatment in both the genotypes. Renal
tumor-free survival after
Fe-NTA treatment was marginally different (P = 0.157) between the two genotypes. Array-based comparative genome hybridization analyses revealed, in RCC, the loss of heterozygosity in chromosomes 4 and 12 without p16INKA inactivation; these results were confirmed by a methylation analysis and showed no significant difference between the genotypes.
Lymphomas showed a preference for genomic amplifications. Dlk1 inactivation by promoter methylation may be involved in
carcinogenesis in both
tumors.
Fe-NTA-induced murine RCCs revealed significantly less genomic aberrations than those in rats, demonstrating a marked species difference.